Cerena Chen
Stock Analyst at Wells Fargo
(2.92)
# 1,681
Out of 5,044 analysts
6
Total ratings
80%
Success rate
25.23%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $284.64 | -81.03% | 1 | Sep 30, 2025 | |
| MTSR Metsera | Initiates: Overweight | $65 | $52.42 | +24.00% | 1 | Jun 20, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $24.18 | +44.75% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $133.51 | +23.59% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $284.64
Upside: -81.03%
Metsera
Jun 20, 2025
Initiates: Overweight
Price Target: $65
Current: $52.42
Upside: +24.00%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $24.18
Upside: +44.75%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $133.51
Upside: +23.59%